CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset. (2nd November 2021) - Maderer, Annett; Fiteni, Frederic; Tanis, Erik; Mauer, Murielle; Schmitt, Thomas; Aust, Daniela E.; Lutz, Manfred P.; Roelofson, Felicitas; Gog, Christiane; Weinmann, Arndt; Koehne, Claus H.; Moehler, Markus; et al.